Physician

Alexandra Elizabeth Zeitany, MD

According to 2025 Medicare claims, Alexandra Zeitany, MD (NPI: 1689036428) practices dermatology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is DAVIE DERMATOLOGY, P.A. (NPI: 1922060649; TIN: 561986321) and primary practice location at 27006-7305.

Zeitany's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 219 traditional Medicare patients, billed 1,547 HCPCS/CPT codes, and received $63,214 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 544 prescription claims across 212 beneficiaries totaling $214,233 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 6 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $7,324 to $63,214. Similarly, Part D prescription costs have risen steadily, from $8,580 to $214,233. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$64K2020 Medicare payment: $7,324 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $41,509 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $39,216 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $63,904 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $63,214 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202047177$7,324
20211771,178$41,509
20221782,472$39,216
20232182,418$63,904
20242191,547$63,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$292K$585K2016 Drug cost: $8,580 (USD; Tot_Drug_Cst)2017 Drug cost: $18,244 (USD; Tot_Drug_Cst)2018 Drug cost: $132,876 (USD; Tot_Drug_Cst)2019 Drug cost: $372,463 (USD; Tot_Drug_Cst)2020 Drug cost: $205,860 (USD; Tot_Drug_Cst)2021 Drug cost: $132,175 (USD; Tot_Drug_Cst)2022 Drug cost: $136,639 (USD; Tot_Drug_Cst)2023 Drug cost: $584,538 (USD; Tot_Drug_Cst)2024 Drug cost: $214,233 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162460$8,580
2017122230$18,244
2018267632$132,876
2019200485$372,463
2020137314$205,860
2021163362$132,175
2022188446$136,639
2023195499$584,538
2024212544$214,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6788$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more114159$57
11102Biopsy of related skin growth, first growth7193$53
17000Destruction of precancer skin growth, 1 growth96119$31
17003Destruction of precancer skin growth, 2-14 growths66438$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab15420$112,255
Clobetasol PropionateClobetasol Propionate691,990$4,072
FluorouracilFluorouracil24778$2,141
Triamcinolone AcetonideTriamcinolone Acetonide842,373$829
MetronidazoleMetronidazole17497$797

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$122ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra Elizabeth Zeitany, MD?

Tedicare shows public-source Medicare data for Alexandra Elizabeth Zeitany, MD (NPI 1689036428), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Elizabeth Zeitany, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandra Elizabeth Zeitany, MD?

Alexandra Elizabeth Zeitany, MD is linked to DAVIE DERMATOLOGY, P.A. (billing NPI 1922060649) in the available physician profile data.

Does Alexandra Elizabeth Zeitany, MD have Open Payments data?

Alexandra Elizabeth Zeitany, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.